Keywords
PirfenidoneARDSMedicineCytokine stormPulmonary fibrosisInflammationIdiopathic pulmonary fibrosisOxidative stressAdverse effectCoronavirus disease 2019 (COVID-19)FibrosisImmunologyDiseaseInternal medicineLungInfectious disease (medical specialty)
Affiliated Institutions
Related Publications
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the pathogen that causes coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has cau...
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Coronavirus disease 2019 (COVID-19) is a novel, viral-induced respiratory disease that in ∼10–15% of patients progresses to acute respiratory distress syndrome (ARDS) triggered ...
Rethinking COVID‐19 ‘pneumonia’ – is this primarily a vaso‐occlusive disease, and can early anticoagulation save the ventilator famine?
As the COVID-19 pandemic rampages around the globe, it remains an enigma as to how a fraction of those infected can turn critically ill with severe hypoxemia – the scale of this...
Publication Info
- Year
- 2020
- Type
- article
- Volume
- 144
- Pages
- 110005-110005
- Citations
- 98
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
98
OpenAlex
Cite This
Soroush Seifirad
(2020).
Pirfenidone: A novel hypothetical treatment for COVID-19.
Medical Hypotheses
, 144
, 110005-110005.
https://doi.org/10.1016/j.mehy.2020.110005
Identifiers
- DOI
- 10.1016/j.mehy.2020.110005